Velarion Records
Free. Unsubscribe any time.

REGENERON PHARMACEUTICALS, INC. (REGN)

REGENERON PHARMACEUTICALS, INC. filed 13 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 77 transactions and 10,480 shares. None carries the SEC's AFF10B5ONE flag; all 13 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in REGENERON PHARMACEUTICALS, INC. 77

Adoption dates in REGENERON PHARMACEUTICALS, INC. 6

Results prints in REGENERON PHARMACEUTICALS, INC. 0

Trades before a print in REGENERON PHARMACEUTICALS, INC. 0

Interval to REGENERON PHARMACEUTICALS, INC.’s next reported results date

How the interval and sources are counted →

Adoption dates REGENERON PHARMACEUTICALS, INC. states

Filing text: “10b5-1(c) adopted on October 31, 2025”

Sources: SEC EDGAR full-text search and the SEC submissions API.